INDUSTRY NEWS
🇪🇺European Union ECHA: One Hazardous Chemical Added to SVHC Candidate List On June 10, 2022, the European Chemicals Agency (ECHA) added N-(hydroxymeth…
In September 2020 and 2021, China National Medical Products Administration (NMPA) released the first and the second draft of Good Manufacturing Practi…
On June 1, China Center for Drug Evaluation (CDE) released the 2021 China Drug Evaluation Report. ChemLinked BaiPharm Team selected excerpts from the …
On June 29, 2022, China National Healthcare Security Administration (NHSA) issued the Work Plan for Adjusting the 2022 National Reimbursement Drug Lis…
🇨🇳Chinese Mainland China to Revise 4 Regulations on Safety Management of Hazardous Chemicals One of China’s MEM officials discloses that the revisions…
Although the review period of the HC Safe Production Permit and HC Safe Use Permit is to be shortened from 45 working days to 30 working days, relevan…
On June 26, 2022, China Center for Food and Drug Inspections (CFDI), a public institution under National Medical Products Administration (NMPA), issue…
Helsinki, June 2022. After two years of virtual gatherings, the capital of Nordic Finland, headquarters to the European Chemicals Agency (ECHA) and bi…
On June 20, 2022, the General Administration of Customs, P.R. China (GACC) released an announcement modifying the declaration requirements for some im…
On June 20, China National Joint Drug Procurement Office announced the start of the 7th round of volume-based procurement (VBP), covering 59 drugs wit…